APO Research
Talk to an analyst

APO RESEARCH · REPORT

Virus Bank Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Virus Bank Manufacturing Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchVirus Bank Manufacturing Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Virus Bank Manufacturing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Virus Bank Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Virus Bank Manufacturing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Virus Bank Manufacturing Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Virus Bank Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Virus Bank Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Virus Bank Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Virus Bank Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Virus Bank Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Virus Bank Manufacturing market include Clean Cells, Sigma-Aldrich, ReciBioPharm, ViruSure, Cell and Gene, Naobios, TFBS Bioscience, Inc., Catalent Biologics and SK pharmteco, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Virus Bank Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Virus Bank Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Virus Bank Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Virus Bank Manufacturing market.

Virus Bank Manufacturing Segment by Company

Clean Cells

Sigma-Aldrich

ReciBioPharm

ViruSure

Cell and Gene

Naobios

TFBS Bioscience, Inc.

Catalent Biologics

SK pharmteco

Charles River Laboratories

SGS SA

Virus Bank Manufacturing Segment by Type

Master Virus Seeds Stocks

Working Virus Seeds Stocks

Virus Bank Manufacturing Segment by Application

Biological Vaccines

Gene Therapy

Others

Virus Bank Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Virus Bank Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Virus Bank Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Virus Bank Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Virus Bank Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Virus Bank Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Virus Bank Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Virus Bank Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Virus Bank Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Virus Bank Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Virus Bank Manufacturing industry.

Chapter 3: Detailed analysis of Virus Bank Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Virus Bank Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Virus Bank Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Virus Bank Manufacturing Industry Trends Table 2. Virus Bank Manufacturing Industry Drivers Table 3. Virus Bank Manufacturing Industry Opportunities and Challenges Table 4. Virus Bank Manufacturing Industry Restraints Table 5. Global Virus Bank Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Virus Bank Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Virus Bank Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Virus Bank Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Virus Bank Manufacturing Company, Product Type & Application Table 10. Global Virus Bank Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Virus Bank Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Master Virus Seeds Stocks Table 15. Significant Companies of Working Virus Seeds Stocks Table 16. Global Virus Bank Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Virus Bank Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Virus Bank Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Virus Bank Manufacturing Sales Value Share by Type (2021-2026) Table 20. Global Virus Bank Manufacturing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biological Vaccines Table 22. Significant Companies of Gene Therapy Table 23. Significant Companies of Others Table 24. Global Virus Bank Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Virus Bank Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Virus Bank Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Virus Bank Manufacturing Sales Value Share by Application (2021-2026) Table 28. Global Virus Bank Manufacturing Sales Value Share by Application (2027-2032) Table 29. Global Virus Bank Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Virus Bank Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Virus Bank Manufacturing Sales Value Share by Region (2021-2026) Table 32. Global Virus Bank Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Virus Bank Manufacturing Sales Value Share by Region (2027-2032) Table 34. Global Virus Bank Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Virus Bank Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Virus Bank Manufacturing Sales Value Market Share by Country (2021-2026) Table 37. Global Virus Bank Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Virus Bank Manufacturing Sales Value Market Share by Country (2027-2032) Table 39. Clean Cells Company Information Table 40. Clean Cells Business Overview Table 41. Clean Cells Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Clean Cells Virus Bank Manufacturing Product Portfolio Table 43. Clean Cells Recent Development Table 44. Sigma-Aldrich Company Information Table 45. Sigma-Aldrich Business Overview Table 46. Sigma-Aldrich Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Sigma-Aldrich Virus Bank Manufacturing Product Portfolio Table 48. Sigma-Aldrich Recent Development Table 49. ReciBioPharm Company Information Table 50. ReciBioPharm Business Overview Table 51. ReciBioPharm Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. ReciBioPharm Virus Bank Manufacturing Product Portfolio Table 53. ReciBioPharm Recent Development Table 54. ViruSure Company Information Table 55. ViruSure Business Overview Table 56. ViruSure Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. ViruSure Virus Bank Manufacturing Product Portfolio Table 58. ViruSure Recent Development Table 59. Cell and Gene Company Information Table 60. Cell and Gene Business Overview Table 61. Cell and Gene Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Cell and Gene Virus Bank Manufacturing Product Portfolio Table 63. Cell and Gene Recent Development Table 64. Naobios Company Information Table 65. Naobios Business Overview Table 66. Naobios Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Naobios Virus Bank Manufacturing Product Portfolio Table 68. Naobios Recent Development Table 69. TFBS Bioscience, Inc. Company Information Table 70. TFBS Bioscience, Inc. Business Overview Table 71. TFBS Bioscience, Inc. Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. TFBS Bioscience, Inc. Virus Bank Manufacturing Product Portfolio Table 73. TFBS Bioscience, Inc. Recent Development Table 74. Catalent Biologics Company Information Table 75. Catalent Biologics Business Overview Table 76. Catalent Biologics Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Catalent Biologics Virus Bank Manufacturing Product Portfolio Table 78. Catalent Biologics Recent Development Table 79. SK pharmteco Company Information Table 80. SK pharmteco Business Overview Table 81. SK pharmteco Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. SK pharmteco Virus Bank Manufacturing Product Portfolio Table 83. SK pharmteco Recent Development Table 84. Charles River Laboratories Company Information Table 85. Charles River Laboratories Business Overview Table 86. Charles River Laboratories Virus Bank Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Charles River Laboratories Virus Bank Manufacturing Product Portfolio Table 88. Charles River Laboratories Recent Development Table 89. SGS SA Company Information Table 90. SGS SA Business Overview Table 91. SGS SA Virus Bank Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. SGS SA Virus Bank Manufacturing Product Portfolio Table 93. SGS SA Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Virus Bank Manufacturing Product Image Figure 2. Global Virus Bank Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Virus Bank Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Virus Bank Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Master Virus Seeds Stocks Image Figure 8. Working Virus Seeds Stocks Image Figure 9. Global Virus Bank Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Virus Bank Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Virus Bank Manufacturing Sales Value Share by Type (2021-2032) Figure 12. Biological Vaccines Image Figure 13. Gene Therapy Image Figure 14. Others Image Figure 15. Global Virus Bank Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Virus Bank Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Virus Bank Manufacturing Sales Value Share by Application (2021-2032) Figure 18. Global Virus Bank Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Virus Bank Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Virus Bank Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Virus Bank Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Virus Bank Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Virus Bank Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Virus Bank Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Virus Bank Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Virus Bank Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Virus Bank Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Virus Bank Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Virus Bank Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Virus Bank Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Master Virus Seeds Stocks
  • Working Virus Seeds Stocks
Applications
  • Biological Vaccines
  • Gene Therapy
  • Others
Companies covered
  • Clean Cells
  • Sigma-Aldrich
  • ReciBioPharm
  • ViruSure
  • Cell and Gene
  • Naobios
  • TFBS Bioscience, Inc.
  • Catalent Biologics
  • SK pharmteco
  • Charles River Laboratories
  • SGS SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Virus Bank Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Virus Bank Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Virus Bank Manufacturing Market Dynamics
  1. 2.1 Virus Bank Manufacturing Industry Trends
  2. 2.2 Virus Bank Manufacturing Industry Drivers
  3. 2.3 Virus Bank Manufacturing Industry Opportunities and Challenges
  4. 2.4 Virus Bank Manufacturing Industry Restraints
3 Virus Bank Manufacturing Market by Company
  1. 3.1 Global Virus Bank Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Virus Bank Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Virus Bank Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Virus Bank Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Virus Bank Manufacturing Company Product Type and Application
  6. 3.6 Global Virus Bank Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Virus Bank Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Virus Bank Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Virus Bank Manufacturing Market by Type
  1. 4.1 Virus Bank Manufacturing Type Introduction
  2. 4.1.1 Master Virus Seeds Stocks
  3. 4.1.2 Working Virus Seeds Stocks
  4. 4.2 Global Virus Bank Manufacturing Sales Value by Type
  5. 4.2.1 Global Virus Bank Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Virus Bank Manufacturing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Virus Bank Manufacturing Sales Value Share by Type (2021-2032)
5 Virus Bank Manufacturing Market by Application
  1. 5.1 Virus Bank Manufacturing Application Introduction
  2. 5.1.1 Biological Vaccines
  3. 5.1.2 Gene Therapy
  4. 5.1.3 Others
  5. 5.2 Global Virus Bank Manufacturing Sales Value by Application
  6. 5.2.1 Global Virus Bank Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Virus Bank Manufacturing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Virus Bank Manufacturing Sales Value Share by Application (2021-2032)
6 Virus Bank Manufacturing Regional Value Analysis
  1. 6.1 Global Virus Bank Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Virus Bank Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Virus Bank Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Virus Bank Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Virus Bank Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Virus Bank Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Virus Bank Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Virus Bank Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Virus Bank Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Virus Bank Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Virus Bank Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Virus Bank Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Virus Bank Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Virus Bank Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Virus Bank Manufacturing Country-level Value Analysis
  1. 7.1 Global Virus Bank Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Virus Bank Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Virus Bank Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Virus Bank Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Virus Bank Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Virus Bank Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Virus Bank Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Clean Cells
  2. 8.1.1 Clean Cells Company Information
  3. 8.1.2 Clean Cells Business Overview
  4. 8.1.3 Clean Cells Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Clean Cells Virus Bank Manufacturing Product Portfolio
  6. 8.1.5 Clean Cells Recent Developments
  7. 8.2 Sigma-Aldrich
  8. 8.2.1 Sigma-Aldrich Company Information
  9. 8.2.2 Sigma-Aldrich Business Overview
  10. 8.2.3 Sigma-Aldrich Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sigma-Aldrich Virus Bank Manufacturing Product Portfolio
  12. 8.2.5 Sigma-Aldrich Recent Developments
  13. 8.3 ReciBioPharm
  14. 8.3.1 ReciBioPharm Company Information
  15. 8.3.2 ReciBioPharm Business Overview
  16. 8.3.3 ReciBioPharm Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ReciBioPharm Virus Bank Manufacturing Product Portfolio
  18. 8.3.5 ReciBioPharm Recent Developments
  19. 8.4 ViruSure
  20. 8.4.1 ViruSure Company Information
  21. 8.4.2 ViruSure Business Overview
  22. 8.4.3 ViruSure Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ViruSure Virus Bank Manufacturing Product Portfolio
  24. 8.4.5 ViruSure Recent Developments
  25. 8.5 Cell and Gene
  26. 8.5.1 Cell and Gene Company Information
  27. 8.5.2 Cell and Gene Business Overview
  28. 8.5.3 Cell and Gene Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cell and Gene Virus Bank Manufacturing Product Portfolio
  30. 8.5.5 Cell and Gene Recent Developments
  31. 8.6 Naobios
  32. 8.6.1 Naobios Company Information
  33. 8.6.2 Naobios Business Overview
  34. 8.6.3 Naobios Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Naobios Virus Bank Manufacturing Product Portfolio
  36. 8.6.5 Naobios Recent Developments
  37. 8.7 TFBS Bioscience, Inc.
  38. 8.7.1 TFBS Bioscience, Inc. Company Information
  39. 8.7.2 TFBS Bioscience, Inc. Business Overview
  40. 8.7.3 TFBS Bioscience, Inc. Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 TFBS Bioscience, Inc. Virus Bank Manufacturing Product Portfolio
  42. 8.7.5 TFBS Bioscience, Inc. Recent Developments
  43. 8.8 Catalent Biologics
  44. 8.8.1 Catalent Biologics Company Information
  45. 8.8.2 Catalent Biologics Business Overview
  46. 8.8.3 Catalent Biologics Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Catalent Biologics Virus Bank Manufacturing Product Portfolio
  48. 8.8.5 Catalent Biologics Recent Developments
  49. 8.9 SK pharmteco
  50. 8.9.1 SK pharmteco Company Information
  51. 8.9.2 SK pharmteco Business Overview
  52. 8.9.3 SK pharmteco Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SK pharmteco Virus Bank Manufacturing Product Portfolio
  54. 8.9.5 SK pharmteco Recent Developments
  55. 8.10 Charles River Laboratories
  56. 8.10.1 Charles River Laboratories Company Information
  57. 8.10.2 Charles River Laboratories Business Overview
  58. 8.10.3 Charles River Laboratories Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Charles River Laboratories Virus Bank Manufacturing Product Portfolio
  60. 8.10.5 Charles River Laboratories Recent Developments
  61. 8.11 SGS SA
  62. 8.11.1 SGS SA Company Information
  63. 8.11.2 SGS SA Business Overview
  64. 8.11.3 SGS SA Virus Bank Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SGS SA Virus Bank Manufacturing Product Portfolio
  66. 8.11.5 SGS SA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst